Business

Today, 60% of all healthcare payments are in some form of value-based care if you include fee for service with quality metrics for upside bonuses, says Dave Snow, CEO of Cedar Gate Technologies.

Also, Neurophet will tap into Roche's data to further improve its brain scan analysis AI.

The acquisition comes amid OpenEvidence's lawsuit alleging that Pathway Medical stole trade secrets, which Pathway has denied.

MaineHealth's Lizzy Mulcahy, DNP, and Dr. Tracy Jalbuena discuss the importance of sharing data with stakeholders and partners as well as how to get more patients involved and interested.

The company also disclosed that it reached an agreement with most holders of its Series A and Series B warrants to convert those warrants into common stock.

Challenges such as workforce shortages that are not getting any better and tight funding are driving the healthcare industry toward AI deployment, says Rob Havasy, HIMSS senior director of informatics strategy.

The company says the model excels in healthcare applications, outperforming previous models on real-world clinical tasks and is already being adopted by healthcare companies.

The company said it plans to develop its new Chai‑2 platform to design, from square one, completely new antibodies for viruses and cancer.

The acquisition will help Datavant transition its manual health records request process to digital.

Data reveals that the people who are enrolling in Medicare Advantage have 50% more chronic conditions than people who are enrolling in Medicare fee-for-service, says Christie Teigland, Inovalon's VP of research science and advanced analytics.